Thrivent Financial For Lutherans Boston Scientific Corp Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Boston Scientific Corp stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 366,807 shares of BSX stock, worth $33.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
366,807
Previous 333,963 9.83%
Holding current value
$33.7 Million
Previous $25.7 Million 19.53%
% of portfolio
0.06%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$72.96 - $84.0 $2.4 Million - $2.76 Million
32,844 Added 9.83%
366,807 $30.7 Million
Q2 2024

Aug 13, 2024
BUY
$67.33 - $77.71 $9.39 Million - $10.8 Million
139,392 Added 71.64%
333,963 $25.7 Million
Q1 2024

May 14, 2024
SELL
$57.6 - $68.62 $352,857 - $420,366
-6,126 Reduced 3.05%
194,571 $13.3 Million
Q4 2023

Feb 14, 2024
SELL
$48.64 - $57.81 $76,948 - $91,455
-1,582 Reduced 0.78%
200,697 $11.6 Million
Q3 2023

Nov 14, 2023
BUY
$50.19 - $54.68 $1.18 Million - $1.28 Million
23,424 Added 13.1%
202,279 $10.7 Million
Q2 2023

Aug 14, 2023
BUY
$49.72 - $54.64 $5.54 Million - $6.09 Million
111,391 Added 165.11%
178,855 $9.67 Million
Q1 2023

May 17, 2023
BUY
$45.09 - $50.03 $11,001 - $12,207
244 Added 0.36%
67,464 $3.37 Million
Q4 2022

Feb 08, 2023
BUY
$39.56 - $47.22 $200,925 - $239,830
5,079 Added 8.17%
67,220 $3.11 Million
Q3 2022

Nov 14, 2022
SELL
$36.71 - $109.66 $218,608 - $653,025
-5,955 Reduced 8.75%
62,141 $2.41 Million
Q2 2022

Aug 16, 2022
SELL
$35.24 - $47.1 $210,206 - $280,951
-5,965 Reduced 8.05%
68,096 $2.54 Million
Q1 2022

May 13, 2022
SELL
$40.9 - $45.1 $155,338 - $171,289
-3,798 Reduced 4.88%
74,061 $3.28 Million
Q4 2021

Feb 16, 2022
BUY
$38.07 - $44.87 $44,085 - $51,959
1,158 Added 1.51%
77,859 $3.31 Million
Q3 2021

Nov 15, 2021
BUY
$41.23 - $45.88 $646,239 - $719,123
15,674 Added 25.68%
76,701 $3.33 Million
Q2 2021

Aug 19, 2021
BUY
$38.58 - $44.24 $10,339 - $11,856
268 Added 0.44%
61,027 $2.61 Million
Q1 2021

May 17, 2021
SELL
$35.27 - $39.67 $49,977 - $56,212
-1,417 Reduced 2.28%
60,759 $2.35 Million
Q4 2020

Feb 16, 2021
SELL
$33.15 - $41.97 $71,935 - $91,074
-2,170 Reduced 3.37%
62,176 $2.24 Million
Q3 2020

Nov 10, 2020
SELL
$34.44 - $42.23 $40,294 - $49,409
-1,170 Reduced 1.79%
64,346 $2.46 Million
Q2 2020

Aug 12, 2020
BUY
$30.19 - $39.11 $59,987 - $77,711
1,987 Added 3.13%
65,516 $2.3 Million
Q4 2019

Feb 13, 2020
BUY
$37.87 - $45.37 $10,035 - $12,023
265 Added 0.42%
63,529 $2.87 Million
Q3 2019

Nov 14, 2019
BUY
$40.31 - $43.45 $12,173 - $13,121
302 Added 0.48%
63,264 $2.57 Million
Q2 2019

Aug 13, 2019
BUY
$34.91 - $42.98 $40,251 - $49,555
1,153 Added 1.87%
62,962 $2.71 Million
Q1 2019

May 14, 2019
SELL
$32.91 - $40.75 $825,119 - $1.02 Million
-25,072 Reduced 28.86%
61,809 $2.37 Million
Q4 2018

Feb 15, 2019
BUY
$31.73 - $39.04 $33,760 - $41,538
1,064 Added 1.24%
86,881 $3.07 Million
Q3 2018

Nov 15, 2018
SELL
$32.83 - $38.63 $4.28 Million - $5.03 Million
-130,239 Reduced 60.28%
85,817 $3.3 Million
Q2 2018

Aug 14, 2018
BUY
$26.84 - $34.32 $16,909 - $21,621
630 Added 0.29%
216,056 $7.07 Million
Q1 2018

May 08, 2018
BUY
$25.2 - $28.54 $4.03 Million - $4.56 Million
159,749 Added 286.92%
215,426 $5.89 Million
Q4 2017

Feb 14, 2018
BUY
$24.79 - $29.8 $25,062 - $30,127
1,011 Added 1.85%
55,677 $1.38 Million
Q3 2017

Nov 14, 2017
BUY
$26.26 - $29.17 $1.44 Million - $1.59 Million
54,666
54,666 $1.59 Million

Others Institutions Holding BSX

# of Institutions
1,542
Shares Held
1.19B
Call Options Held
6.79M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $132B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email